Methicillin-ResistantStaphylococcus aureus*
- 28 September 1967
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 277 (13) , 678-680
- https://doi.org/10.1056/nejm196709282771303
Abstract
THE number of patients with infections caused by methicillin-resistant, coagulase-positive strains of Staphylococcus aureus in Europe has increased,1 2 3 and the recent detection of similar strains in Seattle,4 , 5 Chapel Hill, North Carolina, Columbia, South Carolina, Houston, Texas, and New York City indicates that such resistant strains may become as prevalent in this country as they are elsewhere. These strains are usually resistant to penicillin, methicillin, erythromycin, chloramphenicol, tetracycline and kanamycin, and patients infected often die in spite of antibiotic treatment.3 Bulger,5 who found in vitro synergism by kanamycin and cephalothin against 9 strains of Staph. aureus that were resistant to methicillin, . . .This publication has 6 references indexed in Scilit:
- IN-VITRO ACTIVITY OF CEPHALOTHIN/KANAMYCIN AND METHICILLIN/KANAMYCIN COMBINATIONS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1967
- PENICILLINASE PRODUCTION AND INTRINSIC RESISTANCE TO PENICILLINS IN STAPHYLOCOCCUS AUREUSThe Lancet, 1966
- Methods and significance of in vitro testing of bacterial sensitivity to drugsThe American Journal of Medicine, 1965
- Resistance of Coagulase-Positive Staphylococci to Methicillin and OxacillinJournal of Bacteriology, 1965
- INACTIVATION OF METHICILLIN, OXACILLIN, CLOXACILLIN, AND CEPHALOTHIN BY STAPHYLOCOCCAL PENICILLINASEActa Pathologica Microbiologica Scandinavica, 1964